Jan 8, 2020
For many patients living with type 2 diabetes, daily injections are a substantial barrier to accessing current treatments. “I literally break down every time I have my bloods done,” one diabetes patient shares of her experience. Another adds, “I have the worst needle...
Nov 1, 2019
Most patients have never heard of the Institute for Clinical and Economic Review, but it plays a central role in deciding our access to the treatments prescribed by our doctors. That’s because ICER works with insurance companies to evaluate how medical treatments...
Oct 13, 2019
Patients living with sickle cell disease could run into more insurance barriers as a result of a pending report on two potentially groundbreaking SCD treatments. The Institute for Clinical and Economic Review, which receives support from insurance companies, has begun...
Oct 11, 2019
Alzheimer’s disease exacts a devastating toll on patients and caregivers. “Many people end up in long-term care or nursing homes, and require around-the-clock care for many years,”explains Keith Fargo, director of scientific programs and outreach for the...
Sep 23, 2019
A controversial healthcare formula that is frequently used to deny patients care and boost insurance profits could soon be banned in Massachusetts. Three Massachusetts state representatives, Angelo J. Puppolo, Jr., José F. Tosado and Bud L. Williams, have introduced...
Aug 28, 2019
They’re considered the first line treatment choice for millions of patients living with cardiovascular disease and high cholesterol. But, for many patients living with cardiovascular disease, statins alone don’t work. “My legs were hurting. I thought I was getting the...
